फलो गर्नुहोस्
Englishनेपाली
← पछाडि

Cyclomune Eye Drop

जेनेरिक: Cyclosporine 0.05% Eye prep
Eye Drop१ ब्रान्ड · १ निर्माता
Cyclomune भनेको Cyclosporine 0.05% Eye prep हो। यो Sun Pharmaceutical Industries Ltd. ले बनाएको ब्रान्ड उत्पादन हो। यो नेपालमा 3ml प्याकमा उपलब्ध छ।
ब्रान्ड (Brand)Cyclomune
सामान्य नाम (Generic name)Cyclosporine 0.05% Eye prep
निर्माता (Maker)Sun Pharmaceutical Industries Ltd.
रूप (Form)Eye Drop
प्याक (Pack size)3ml
स्रोतNepalDoc medicine catalog

के का लागि

Kidney, Liver, and Heart Transplantation Cyclosporine capsules, USP MODIFIED are indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. Cyclosporine capsules, USP MODIFIED have been used in combination with azathioprine and corticosteroids.

From the U.S. FDA-approved label for Cyclosporine 0.05% Eye prep. Full label: DailyMed.

Kidney, Liver, and Heart Transplantation Cyclosporine capsules, USP MODIFIED are indicated for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. Cyclosporine capsules, USP MODIFIED have been used in combination with azathioprine and corticosteroids. Rheumatoid Arthritis Cyclosporine capsules, USP MODIFIED are indicated for the treatment of patients with severe active, rheumatoid arthritis where the disease has not adequately responded to methotrexate. Cyclosporine capsules, USP MODIFIED can be used in combination with methotrexate in rheumatoid arthritis patients who do not respond adequately to methotrexate alone. Psoriasis Cyclosporine capsules, USP MODIFIED are indicated for the treatment of adult, nonimmunocompromised patients with severe (i.e., extensive and/or disabling), recalcitrant, plaque psoriasis who have failed to respond to at least one systemic therapy (e.g., PUVA, retinoids, or methotrexate) or in patients for whom other systemic therapies are contraindicated, or cannot be tolerated. While rebound rarely occurs, most patients will experience relapse with cyclosporine capsules, USP MODIFIED as with other therapies upon cessation of treatment.

From the U.S. FDA-approved label for Cyclosporine 0.05% Eye prep. Full label: DailyMed.

Cyclosporine capsules, USP MODIFIED, soft gelatin capsules, has increased bioavailability in comparison to Sandimmune (cyclosporine capsules, USP). The daily dose of cyclosporine capsules, USP MODIFIED should always be given in two divided doses (BID). It is recommended that cyclosporine capsules, USP MODIFIED be administered on a consistent schedule with regard to time of day and relation to meals.

Directions from the U.S. FDA-approved label for Cyclosporine 0.05% Eye prep — your doctor or pharmacist may advise differently.

General Cyclosporine capsules, USP MODIFIED are contraindicated in patients with a hypersensitivity to cyclosporine or to any of the ingredients of the formulation. Rheumatoid Arthritis Rheumatoid arthritis patients with abnormal renal function, uncontrolled hypertension, or malignancies should not receive cyclosporine capsules, USP MODIFIED. Psoriasis Psoriasis patients who are treated with cyclosporine capsules, USP MODIFIED should not receive concomitant PUVA or UVB therapy, methotrexate or other immunosuppressive agents, coal tar or radiation therapy.

Excerpt from the U.S. FDA-approved label for Cyclosporine 0.05% Eye prep. Talk to a pharmacist or doctor before use.

(See also BOXED WARNING ) All Patients Cyclosporine, the active ingredient of cyclosporine capsules, USP MODIFIED, can cause nephrotoxicity and hepatotoxicity. The risk increases with increasing doses of cyclosporine. Renal dysfunction including structural kidney damage is a potential consequence of cyclosporine capsules, USP MODIFIED and therefore renal function must be monitored during therapy. Care should be taken in using cyclosporine with nephrotoxic drugs (see PRECAUTIONS ).

Warnings and precautions excerpt from the U.S. FDA-approved label for Cyclosporine 0.05% Eye prep — not a complete list. Talk to a pharmacist or doctor before use.

Kidney, Liver, and Heart Transplantation The principal adverse reactions of cyclosporine therapy are renal dysfunction, tremor, hirsutism, hypertension, and gum hyperplasia. Hypertension Hypertension, which is usually mild to moderate, may occur in approximately 50% of patients following renal transplantation and in most cardiac transplant patients.

Excerpt from the U.S. FDA-approved label for Cyclosporine 0.05% Eye prep — not a complete list. Talk to a pharmacist or doctor about side effects.

Store at 20° to 25°C (68° to 77°F). Keep this and all medications out of the reach of children.

Storage information from the U.S. FDA-approved label for Cyclosporine 0.05% Eye prep.

प्रश्न–उत्तर

Cyclomune के हो?

Cyclomune Eye Drop भनेको Cyclosporine 0.05% Eye prep औषधि हो, Sun Pharmaceutical Industries Ltd. ले बनाएको। यो Eye Drop रूपमा पाइन्छ।

Cyclomune को सामान्य नाम के हो?

Cyclomune को सामान्य नाम Cyclosporine 0.05% Eye prep हो।

Cyclomune को मूल्य नेपालमा कति हो?

NepalDoc ले औषधिको मूल्य सूचीबद्ध गर्दैन। मूल्य हरेक फार्मेसीले आफैं तय गर्छ र समयसँगै परिवर्तन हुन्छ — यो पृष्ठले नेपालमा बिक्री हुने ब्रान्ड, यसको सामान्य नाम, निर्माता, शक्ति र प्याक विवरण पुष्टि गर्छ, ताकि तपाईं आफ्नो फार्मेसीमा मूल्य विश्वस्त भएर सोध्न सक्नुहोस्।

पूर्ण औषधि गाइड औषधि बोर्डमा जाँच गर्नुहोस्
+ Safety information

यो पृष्ठ सामान्य जानकारीका लागि मात्र हो, चिकित्सकीय सल्लाह होइन। औषधिको विवरण माथि उल्लेखित स्रोतहरूबाट आएको हो र परिवर्तन हुन सक्छ — प्रयोग गर्नुअघि डाक्टर वा फार्मासिस्टसँग औषधि, शक्ति र मात्रा पुष्टि गर्नुहोस्। सूचीमा हुनुले कुनै फार्मेसीमा औषधि उपलब्ध छ भन्ने ग्यारेन्टी दिँदैन।

यो सेयर गर्नुहोस्
NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.
No prices are shown — NepalDoc lists medicine information only.